JP2009504710A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009504710A5 JP2009504710A5 JP2008526493A JP2008526493A JP2009504710A5 JP 2009504710 A5 JP2009504710 A5 JP 2009504710A5 JP 2008526493 A JP2008526493 A JP 2008526493A JP 2008526493 A JP2008526493 A JP 2008526493A JP 2009504710 A5 JP2009504710 A5 JP 2009504710A5
- Authority
- JP
- Japan
- Prior art keywords
- cellulose
- pancreatin
- micropellet core
- mixture
- pancreatine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010019160 Pancreatin Proteins 0.000 claims description 16
- 229940055695 pancreatin Drugs 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 15
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 10
- 239000002702 enteric coating Substances 0.000 claims description 9
- 238000009505 enteric coating Methods 0.000 claims description 9
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims description 8
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 6
- -1 carboxymethyl ethyl Chemical group 0.000 claims description 6
- 229920002301 cellulose acetate Polymers 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 239000001856 Ethyl cellulose Substances 0.000 claims description 5
- 229960000541 cetyl alcohol Drugs 0.000 claims description 5
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 5
- 229920001249 ethyl cellulose Polymers 0.000 claims description 5
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 claims description 5
- 239000004014 plasticizer Substances 0.000 claims description 5
- 239000001069 triethyl citrate Substances 0.000 claims description 5
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims description 5
- 235000013769 triethyl citrate Nutrition 0.000 claims description 5
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims description 4
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 claims description 4
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- 244000215068 Acacia senegal Species 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- 229920002101 Chitin Polymers 0.000 claims description 3
- 241000206575 Chondrus crispus Species 0.000 claims description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 3
- 229920000084 Gum arabic Polymers 0.000 claims description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- MKRNVBXERAPZOP-UHFFFAOYSA-N Starch acetate Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OC(C)=O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 MKRNVBXERAPZOP-UHFFFAOYSA-N 0.000 claims description 3
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 235000010489 acacia gum Nutrition 0.000 claims description 3
- 239000000205 acacia gum Substances 0.000 claims description 3
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims description 3
- IYKJEILNJZQJPU-UHFFFAOYSA-N acetic acid;butanedioic acid Chemical compound CC(O)=O.OC(=O)CCC(O)=O IYKJEILNJZQJPU-UHFFFAOYSA-N 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 3
- 239000011976 maleic acid Substances 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 235000010981 methylcellulose Nutrition 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 229940100467 polyvinyl acetate phthalate Drugs 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 229940068984 polyvinyl alcohol Drugs 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 2
- 229920001800 Shellac Polymers 0.000 claims 2
- 229960001631 carbomer Drugs 0.000 claims 2
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical group CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 2
- 229960002900 methylcellulose Drugs 0.000 claims 2
- 229960000292 pectin Drugs 0.000 claims 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims 2
- 239000004208 shellac Substances 0.000 claims 2
- 229940113147 shellac Drugs 0.000 claims 2
- 235000013874 shellac Nutrition 0.000 claims 2
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims 2
- 239000011230 binding agent Substances 0.000 claims 1
- 239000002981 blocking agent Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000002253 acid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 102100028675 DNA polymerase subunit gamma-2, mitochondrial Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 101000837415 Homo sapiens DNA polymerase subunit gamma-2, mitochondrial Proteins 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108010067035 Pancrelipase Proteins 0.000 description 1
- 230000003625 amylolytic effect Effects 0.000 description 1
- 229940092125 creon Drugs 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70852605P | 2005-08-15 | 2005-08-15 | |
| US60/708,526 | 2005-08-15 | ||
| EP05107474.8 | 2005-08-15 | ||
| EP05107474 | 2005-08-15 | ||
| PCT/EP2006/065313 WO2007020260A2 (en) | 2005-08-15 | 2006-08-15 | Pancreatin micropellet cores suitable for enteric coating |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009504710A JP2009504710A (ja) | 2009-02-05 |
| JP2009504710A5 true JP2009504710A5 (https=) | 2009-07-09 |
| JP5284092B2 JP5284092B2 (ja) | 2013-09-11 |
Family
ID=37401623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008526493A Active JP5284092B2 (ja) | 2005-08-15 | 2006-08-15 | 腸溶コーティングに適したパンクレアチンマイクロペレットコア |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1931317B1 (https=) |
| JP (1) | JP5284092B2 (https=) |
| KR (1) | KR101302841B1 (https=) |
| AT (1) | ATE418329T1 (https=) |
| AU (1) | AU2006281415B2 (https=) |
| CA (1) | CA2619477C (https=) |
| DE (1) | DE602006004471D1 (https=) |
| ES (1) | ES2320174T3 (https=) |
| IL (1) | IL189457A (https=) |
| MX (1) | MX2008001557A (https=) |
| NO (1) | NO20081379L (https=) |
| PL (1) | PL1931317T3 (https=) |
| PT (1) | PT1931317E (https=) |
| RU (1) | RU2408364C2 (https=) |
| WO (1) | WO2007020260A2 (https=) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6632429B1 (en) | 1999-12-17 | 2003-10-14 | Joan M. Fallon | Methods for treating pervasive development disorders |
| US20070053895A1 (en) | 2000-08-14 | 2007-03-08 | Fallon Joan M | Method of treating and diagnosing parkinsons disease and related dysautonomic disorders |
| IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
| US8030002B2 (en) | 2000-11-16 | 2011-10-04 | Curemark Llc | Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions |
| CA2560613C (en) | 2004-03-22 | 2015-11-24 | Solvay Pharmaceuticals Gmbh | Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
| KR101555058B1 (ko) | 2005-07-29 | 2015-09-22 | 애보트 래버러토리즈 게엠베하 | 살균된 판크레아틴 분말의 제조방법 |
| US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
| US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
| US20080058282A1 (en) | 2005-08-30 | 2008-03-06 | Fallon Joan M | Use of lactulose in the treatment of autism |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
| JP5966202B2 (ja) | 2007-02-20 | 2016-08-10 | アラガン ファーマシューティカルズ インターナショナル リミテッド | 安定な消化酵素組成物 |
| WO2009083607A1 (en) * | 2008-01-03 | 2009-07-09 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders |
| US10087493B2 (en) | 2008-03-07 | 2018-10-02 | Aptalis Pharma Canada Ulc | Method for detecting infectious parvovirus in pharmaceutical preparations |
| US8658163B2 (en) | 2008-03-13 | 2014-02-25 | Curemark Llc | Compositions and use thereof for treating symptoms of preeclampsia |
| US8084025B2 (en) | 2008-04-18 | 2011-12-27 | Curemark Llc | Method for the treatment of the symptoms of drug and alcohol addiction |
| US9320780B2 (en) | 2008-06-26 | 2016-04-26 | Curemark Llc | Methods and compositions for the treatment of symptoms of Williams Syndrome |
| PL2318035T3 (pl) | 2008-07-01 | 2019-10-31 | Curemark Llc | Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego |
| US10776453B2 (en) | 2008-08-04 | 2020-09-15 | Galenagen, Llc | Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain |
| US20100092447A1 (en) | 2008-10-03 | 2010-04-15 | Fallon Joan M | Methods and compositions for the treatment of symptoms of prion diseases |
| KR20170005191A (ko) | 2009-01-06 | 2017-01-11 | 큐어론 엘엘씨 | 이. 콜라이에 의한 구강 감염의 치료 또는 예방을 위한 조성물 및 방법 |
| CN102300989B (zh) | 2009-01-06 | 2015-12-09 | 柯尔朗恩有限责任公司 | 用于治疗或预防金黄色葡萄球菌感染以及用于根除或减少表面上金黄色葡萄球菌的组合物和方法 |
| US9056050B2 (en) | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
| US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| PL2295039T5 (pl) | 2009-08-28 | 2023-02-27 | Nordmark Pharma Gmbh | Sposób wytwarzania granulek zawierających pankreatynę, w szczególności mikrogranulek zawierających pankreatynę, oraz wytworzone tym sposobem granulki zawierające pankreatynę |
| US9511125B2 (en) | 2009-10-21 | 2016-12-06 | Curemark Llc | Methods and compositions for the treatment of influenza |
| ES2657673T3 (es) | 2010-10-01 | 2018-03-06 | Aptalis Pharma Limited | Formulaciones recubiertas entéricas de pancrelipasa, de baja intensidad |
| DE202011000728U1 (de) | 2011-03-30 | 2011-06-09 | Nordmark Arzneimittel GmbH & Co. KG, 25436 | Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets |
| EP2489349B1 (de) | 2011-02-17 | 2014-05-28 | Nordmark Arzneimittel GmbH & Co.KG | Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und Verfahren zu deren Herstellung |
| US8980252B2 (en) | 2011-04-21 | 2015-03-17 | Curemark Llc | Methods of treatment of schizophrenia |
| CA2843556A1 (en) | 2011-08-08 | 2013-02-14 | Aptalis Pharma Ltd. | Method for dissolution testing of solid compositions containing digestive enzymes |
| US10350278B2 (en) * | 2012-05-30 | 2019-07-16 | Curemark, Llc | Methods of treating Celiac disease |
| US10184121B2 (en) | 2013-06-28 | 2019-01-22 | Allergan Pharmaceuticals International Limited | Methods for removing viral contaminants from pancreatic extracts |
| CA2920844A1 (en) | 2013-08-09 | 2015-02-12 | Allergan Pharmaceuticals International Limited | Digestive enzyme composition suitable for enteral administration |
| EP3215181B1 (en) | 2014-11-05 | 2024-12-18 | Abbott Laboratories GmbH | Processes for producing compositions with improved safety profile comprising pancreatin and compositions suitable for pharmaceutical use |
| DE102017104482A1 (de) * | 2017-03-03 | 2018-09-06 | Nordmark Arzneimittel Gmbh & Co. Kg | Pharmazeutische Zusammensetzung umfassend Pankreatin und einen lipasehaltigen Überzug |
| AU2018250823A1 (en) | 2017-04-10 | 2019-10-17 | Curemark, Llc | Compositions for treating addiction |
| RU2706003C1 (ru) * | 2019-09-09 | 2019-11-13 | Акционерное общество "АВВА РУС" | Микрогранулы, содержащие панкреатин |
| PH12022553091A1 (en) * | 2020-06-10 | 2023-10-16 | Kusum Healthcare Pvt Ltd | Pharmaceutical composition of pancreatin |
| US11541009B2 (en) | 2020-09-10 | 2023-01-03 | Curemark, Llc | Methods of prophylaxis of coronavirus infection and treatment of coronaviruses |
| KR102950325B1 (ko) | 2024-01-26 | 2026-04-08 | 황준영 | 판크레아틴 함유 속방성 장용코팅 정제 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1509866A (en) * | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
| DE4227385A1 (de) * | 1992-08-19 | 1994-02-24 | Kali Chemie Pharma Gmbh | Pankreatinmikropellets |
| KR19990072826A (ko) * | 1998-02-26 | 1999-09-27 | 우재영 | 판크레아틴장용코팅과립의제조방법 |
| UA69413C2 (uk) * | 1998-05-22 | 2004-09-15 | Брістол-Майерс Сквібб Компані | Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції |
| BR0009012A (pt) * | 1999-03-17 | 2001-12-26 | Solvay Pharm Gmbh | Medicamento para o tratamento de diabete |
| IT1319655B1 (it) * | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
| AR032392A1 (es) * | 2001-01-19 | 2003-11-05 | Solvay Pharm Gmbh | Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado. |
-
2006
- 2006-08-15 KR KR1020087006201A patent/KR101302841B1/ko active Active
- 2006-08-15 EP EP06778242A patent/EP1931317B1/en not_active Revoked
- 2006-08-15 DE DE602006004471T patent/DE602006004471D1/de active Active
- 2006-08-15 CA CA2619477A patent/CA2619477C/en active Active
- 2006-08-15 MX MX2008001557A patent/MX2008001557A/es active IP Right Grant
- 2006-08-15 ES ES06778242T patent/ES2320174T3/es active Active
- 2006-08-15 JP JP2008526493A patent/JP5284092B2/ja active Active
- 2006-08-15 PL PL06778242T patent/PL1931317T3/pl unknown
- 2006-08-15 WO PCT/EP2006/065313 patent/WO2007020260A2/en not_active Ceased
- 2006-08-15 PT PT06778242T patent/PT1931317E/pt unknown
- 2006-08-15 AU AU2006281415A patent/AU2006281415B2/en active Active
- 2006-08-15 RU RU2008109651/15A patent/RU2408364C2/ru active
- 2006-08-15 AT AT06778242T patent/ATE418329T1/de active
-
2008
- 2008-02-12 IL IL189457A patent/IL189457A/en active IP Right Grant
- 2008-03-14 NO NO20081379A patent/NO20081379L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009504710A5 (https=) | ||
| JP5284092B2 (ja) | 腸溶コーティングに適したパンクレアチンマイクロペレットコア | |
| Khatri et al. | Role of plasticizer in membrane coated extended release oral drug delivery system | |
| JP5847303B2 (ja) | 医薬品剤形又は機能性食品剤形に適したコーティング組成物 | |
| EP3302444B1 (en) | Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol | |
| US9107451B2 (en) | Coating composition for the dip coating of capsule halves | |
| EP2283830A1 (en) | Aqueous enteric capsule coating | |
| KR20100016306A (ko) | 가속된 약물 방출을 갖는 장용 코팅을 포함하는 고체 투여 형태 | |
| CA2769046A1 (en) | Coating agent for the dip coating of capsule halves | |
| JPWO2017022248A1 (ja) | 腸溶性カプセル | |
| AU2006281414A1 (en) | Controlled release pharmaceutical compositions for acid labile drugs | |
| JP2005539019A (ja) | 錠剤及びカプレットのためのフィルムコーティング | |
| KR20170086063A (ko) | 디메틸 푸마르산염을 포함하는 제약학적 비드 제제 | |
| JP2008534531A (ja) | 調節物質の送達に影響を及ぼすマトリックスを有するペレットを有する多粒子の医薬剤形 | |
| CN103550158A (zh) | 一种大黄素固体分散体、含药丸芯和结肠靶向微丸及其用途 | |
| CN112566668B (zh) | 肠溶性硬胶囊 | |
| Miller et al. | Aqueous polymeric film coating | |
| Phan et al. | The relationship between mucoadhesive polymers and surface coating in tablets for the controlled colonic delivery of a poorly water-soluble drug | |
| EP2182929A2 (en) | Duloxetine formulations | |
| JP2009544684A (ja) | デンプンを含むコーティング組成物 | |
| WO2010078878A1 (en) | Duloxetine formulations | |
| RU2308942C1 (ru) | Энтеросолюбильная оболочка и способ покрытия такой оболочкой твердой фармацевтической композиции | |
| KR20080034515A (ko) | 산 불안정성 약제를 위한 조절방출 약제학적 조성물 | |
| JP2014139210A (ja) | ｐＨ制御パルス送達システム、その調製法及び使用法 |